nodes	percent_of_prediction	percent_of_DWPC	metapath
Pancuronium—CHRNA1—tongue—hypothyroidism	0.0824	0.145	CbGeAlD
Pancuronium—CHRND—heart—hypothyroidism	0.0375	0.0662	CbGeAlD
Pancuronium—CHRND—cardiovascular system—hypothyroidism	0.0354	0.0625	CbGeAlD
Pancuronium—CHRND—thyroid gland—hypothyroidism	0.027	0.0477	CbGeAlD
Pancuronium—CHRNA2—heart—hypothyroidism	0.026	0.0458	CbGeAlD
Pancuronium—CHRNB1—heart—hypothyroidism	0.0242	0.0427	CbGeAlD
Pancuronium—CHRNA1—thyroid gland—hypothyroidism	0.0226	0.0398	CbGeAlD
Pancuronium—Tachycardia—Liothyronine—hypothyroidism	0.022	0.0915	CcSEcCtD
Pancuronium—Hypotension—Liothyronine—hypothyroidism	0.021	0.0876	CcSEcCtD
Pancuronium—Muscular weakness—Dextrothyroxine—hypothyroidism	0.0198	0.0826	CcSEcCtD
Pancuronium—Muscular weakness—Levothyroxine—hypothyroidism	0.0198	0.0826	CcSEcCtD
Pancuronium—CHRNA2—blood—hypothyroidism	0.0194	0.0342	CbGeAlD
Pancuronium—CHRNA2—thyroid gland—hypothyroidism	0.0187	0.033	CbGeAlD
Pancuronium—CHRNB1—adrenal gland—hypothyroidism	0.018	0.0318	CbGeAlD
Pancuronium—CHRNB1—blood—hypothyroidism	0.018	0.0318	CbGeAlD
Pancuronium—CHRNB1—thyroid gland—hypothyroidism	0.0174	0.0307	CbGeAlD
Pancuronium—CHRNB1—female gonad—hypothyroidism	0.0168	0.0297	CbGeAlD
Pancuronium—CHRM2—heart—hypothyroidism	0.0155	0.0273	CbGeAlD
Pancuronium—CHRNB1—testis—hypothyroidism	0.0149	0.0263	CbGeAlD
Pancuronium—CHRNA2—cerebellum—hypothyroidism	0.0148	0.0261	CbGeAlD
Pancuronium—CHRM2—cardiovascular system—hypothyroidism	0.0146	0.0258	CbGeAlD
Pancuronium—Muscular weakness—Liotrix—hypothyroidism	0.0146	0.0608	CcSEcCtD
Pancuronium—Flushing—Dextrothyroxine—hypothyroidism	0.0144	0.0601	CcSEcCtD
Pancuronium—Flushing—Levothyroxine—hypothyroidism	0.0144	0.0601	CcSEcCtD
Pancuronium—CHRNB1—liver—hypothyroidism	0.0141	0.0249	CbGeAlD
Pancuronium—Bronchospasm—Liotrix—hypothyroidism	0.0141	0.0586	CcSEcCtD
Pancuronium—CHRNB1—cerebellum—hypothyroidism	0.0138	0.0243	CbGeAlD
Pancuronium—SLC22A1—blood—hypothyroidism	0.0114	0.02	CbGeAlD
Pancuronium—Tachycardia—Levothyroxine—hypothyroidism	0.0108	0.0449	CcSEcCtD
Pancuronium—Tachycardia—Dextrothyroxine—hypothyroidism	0.0108	0.0449	CcSEcCtD
Pancuronium—SLC22A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.0108	0.0558	CbGpPWpGaD
Pancuronium—Flushing—Liotrix—hypothyroidism	0.0106	0.0442	CcSEcCtD
Pancuronium—BCHE—heart—hypothyroidism	0.0103	0.0182	CbGeAlD
Pancuronium—SLC22A1—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.0101	0.052	CbGpPWpGaD
Pancuronium—BCHE—cardiovascular system—hypothyroidism	0.00972	0.0172	CbGeAlD
Pancuronium—CHRM3—thyroid gland—hypothyroidism	0.00909	0.016	CbGeAlD
Pancuronium—SLC22A1—liver—hypothyroidism	0.00888	0.0157	CbGeAlD
Pancuronium—CHRM3—female gonad—hypothyroidism	0.00878	0.0155	CbGeAlD
Pancuronium—BCHE—pituitary gland—hypothyroidism	0.00861	0.0152	CbGeAlD
Pancuronium—SLC22A2—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00824	0.0427	CbGpPWpGaD
Pancuronium—Anaphylactic shock—Liotrix—hypothyroidism	0.00813	0.0339	CcSEcCtD
Pancuronium—Tachycardia—Liotrix—hypothyroidism	0.00793	0.033	CcSEcCtD
Pancuronium—CHRM3—testis—hypothyroidism	0.00779	0.0137	CbGeAlD
Pancuronium—BCHE—adrenal gland—hypothyroidism	0.00769	0.0136	CbGeAlD
Pancuronium—BCHE—blood—hypothyroidism	0.00769	0.0136	CbGeAlD
Pancuronium—SLC22A1—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00768	0.0398	CbGpPWpGaD
Pancuronium—Hypotension—Liotrix—hypothyroidism	0.0076	0.0316	CcSEcCtD
Pancuronium—BCHE—thyroid gland—hypothyroidism	0.00742	0.0131	CbGeAlD
Pancuronium—Rash—Dextrothyroxine—hypothyroidism	0.00697	0.029	CcSEcCtD
Pancuronium—Rash—Levothyroxine—hypothyroidism	0.00697	0.029	CcSEcCtD
Pancuronium—Dermatitis—Dextrothyroxine—hypothyroidism	0.00696	0.029	CcSEcCtD
Pancuronium—Dermatitis—Levothyroxine—hypothyroidism	0.00696	0.029	CcSEcCtD
Pancuronium—BCHE—testis—hypothyroidism	0.00636	0.0112	CbGeAlD
Pancuronium—BCHE—liver—hypothyroidism	0.00601	0.0106	CbGeAlD
Pancuronium—Hypersensitivity—Liotrix—hypothyroidism	0.00599	0.0249	CcSEcCtD
Pancuronium—CHRND—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00594	0.0307	CbGpPWpGaD
Pancuronium—BCHE—cerebellum—hypothyroidism	0.00587	0.0104	CbGeAlD
Pancuronium—Rash—Liotrix—hypothyroidism	0.00512	0.0213	CcSEcCtD
Pancuronium—Dermatitis—Liotrix—hypothyroidism	0.00512	0.0213	CcSEcCtD
Pancuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00509	0.0264	CbGpPWpGaD
Pancuronium—CHRNA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00505	0.0261	CbGpPWpGaD
Pancuronium—CHRNA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0048	0.0248	CbGpPWpGaD
Pancuronium—CHRND—Neuronal System—SLC5A7—hypothyroidism	0.00455	0.0236	CbGpPWpGaD
Pancuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00433	0.0224	CbGpPWpGaD
Pancuronium—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00422	0.0218	CbGpPWpGaD
Pancuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00411	0.0213	CbGpPWpGaD
Pancuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00393	0.0204	CbGpPWpGaD
Pancuronium—CHRNA1—Neuronal System—SLC5A7—hypothyroidism	0.00387	0.02	CbGpPWpGaD
Pancuronium—CHRND—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00383	0.0198	CbGpPWpGaD
Pancuronium—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—hypothyroidism	0.00383	0.0198	CbGpPWpGaD
Pancuronium—CHRNA2—Neuronal System—SLC5A7—hypothyroidism	0.00368	0.019	CbGpPWpGaD
Pancuronium—CHRNA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00325	0.0168	CbGpPWpGaD
Pancuronium—CHRNA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00309	0.016	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00302	0.0156	CbGpPWpGaD
Pancuronium—CHRND—Neuronal System—NEFL—hypothyroidism	0.00293	0.0152	CbGpPWpGaD
Pancuronium—BCHE—Peptide hormone metabolism—TSHB—hypothyroidism	0.0028	0.0145	CbGpPWpGaD
Pancuronium—BCHE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00265	0.0137	CbGpPWpGaD
Pancuronium—CHRNA1—Neuronal System—NEFL—hypothyroidism	0.00249	0.0129	CbGpPWpGaD
Pancuronium—CHRNA2—Neuronal System—NEFL—hypothyroidism	0.00237	0.0123	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00236	0.0122	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0022	0.0114	CbGpPWpGaD
Pancuronium—BCHE—Neuronal System—SLC5A7—hypothyroidism	0.00203	0.0105	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00194	0.0101	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00192	0.00992	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—SLC5A7—hypothyroidism	0.00181	0.00938	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00179	0.00925	CbGpPWpGaD
Pancuronium—BCHE—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00171	0.00883	CbGpPWpGaD
Pancuronium—BCHE—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.0017	0.00878	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—SLC5A7—hypothyroidism	0.00169	0.00874	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00159	0.00822	CbGpPWpGaD
Pancuronium—SLC22A2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00152	0.00789	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00148	0.00766	CbGpPWpGaD
Pancuronium—SLC22A1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00142	0.00735	CbGpPWpGaD
Pancuronium—BCHE—Neuronal System—NEFL—hypothyroidism	0.00131	0.00677	CbGpPWpGaD
Pancuronium—CHRM3—G alpha (q) signalling events—TRH—hypothyroidism	0.00129	0.00666	CbGpPWpGaD
Pancuronium—CHRM3—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.00123	0.00635	CbGpPWpGaD
Pancuronium—CHRM2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.00121	0.00628	CbGpPWpGaD
Pancuronium—SLC22A2—Neuronal System—NEFL—hypothyroidism	0.00117	0.00604	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00115	0.00596	CbGpPWpGaD
Pancuronium—BCHE—Peptide hormone metabolism—POMC—hypothyroidism	0.0011	0.00568	CbGpPWpGaD
Pancuronium—SLC22A1—Neuronal System—NEFL—hypothyroidism	0.00109	0.00563	CbGpPWpGaD
Pancuronium—BCHE—Peptide hormone metabolism—IGF1—hypothyroidism	0.00106	0.00547	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000974	0.00504	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000908	0.0047	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000852	0.00441	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000844	0.00437	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000807	0.00418	CbGpPWpGaD
Pancuronium—CHRM2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000774	0.00401	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000766	0.00397	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00076	0.00393	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00076	0.00393	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000752	0.00389	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000752	0.00389	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000752	0.00389	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—IYD—hypothyroidism	0.000737	0.00381	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000714	0.0037	CbGpPWpGaD
Pancuronium—CHRM3—G alpha (q) signalling events—AVP—hypothyroidism	0.000676	0.0035	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—IYD—hypothyroidism	0.000658	0.00341	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—TRH—hypothyroidism	0.000649	0.00336	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—TRH—hypothyroidism	0.000643	0.00333	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ATP5O—hypothyroidism	0.000627	0.00324	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—IYD—hypothyroidism	0.000613	0.00318	CbGpPWpGaD
Pancuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000605	0.00313	CbGpPWpGaD
Pancuronium—SLC22A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000603	0.00312	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—TPO—hypothyroidism	0.000589	0.00305	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—TSHB—hypothyroidism	0.000578	0.00299	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—TSHR—hypothyroidism	0.000578	0.00299	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—TSHB—hypothyroidism	0.000573	0.00297	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—TSHR—hypothyroidism	0.000573	0.00297	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—IYD—hypothyroidism	0.000567	0.00293	CbGpPWpGaD
Pancuronium—SLC22A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000562	0.00291	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ATP5O—hypothyroidism	0.00056	0.0029	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000546	0.00283	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of proteins—TSHB—hypothyroidism	0.000529	0.00274	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—TPO—hypothyroidism	0.000526	0.00272	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ATP5O—hypothyroidism	0.000522	0.0027	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—TPO—hypothyroidism	0.00049	0.00254	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ATP5O—hypothyroidism	0.000482	0.00249	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—TPO—hypothyroidism	0.000453	0.00234	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000448	0.00232	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000443	0.00229	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000389	0.00202	CbGpPWpGaD
Pancuronium—CHRM2—G alpha (i) signalling events—POMC—hypothyroidism	0.000371	0.00192	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—TRH—hypothyroidism	0.000367	0.0019	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	0.000363	0.00188	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000363	0.00188	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—AVP—hypothyroidism	0.000341	0.00176	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—AVP—hypothyroidism	0.000338	0.00175	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—TRH—hypothyroidism	0.000333	0.00172	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—TRH—hypothyroidism	0.00033	0.00171	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—TSHB—hypothyroidism	0.000327	0.00169	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—TSHR—hypothyroidism	0.000327	0.00169	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	0.000324	0.00168	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	0.000324	0.00168	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000306	0.00159	CbGpPWpGaD
Pancuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000297	0.00154	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—TSHB—hypothyroidism	0.000297	0.00154	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—TSHR—hypothyroidism	0.000297	0.00154	CbGpPWpGaD
Pancuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000295	0.00153	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	0.000294	0.00152	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	0.000294	0.00152	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000286	0.00148	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—TSHB—hypothyroidism	0.000273	0.00141	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—TSHB—hypothyroidism	0.000244	0.00126	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3C2A—hypothyroidism	0.000243	0.00126	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.00024	0.00124	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CLTC—hypothyroidism	0.000228	0.00118	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—TSHB—hypothyroidism	0.000227	0.00118	CbGpPWpGaD
Pancuronium—CHRM3—GPCR ligand binding—POMC—hypothyroidism	0.000227	0.00117	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CLTC—hypothyroidism	0.000225	0.00117	CbGpPWpGaD
Pancuronium—CHRM2—GPCR ligand binding—POMC—hypothyroidism	0.000224	0.00116	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	0.000217	0.00112	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—TSHB—hypothyroidism	0.00021	0.00109	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of proteins—POMC—hypothyroidism	0.000207	0.00107	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—SLC5A5—hypothyroidism	0.000204	0.00106	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	0.000202	0.00105	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—VAV3—hypothyroidism	0.0002	0.00104	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of proteins—IGF1—hypothyroidism	0.000199	0.00103	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	0.000198	0.00103	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TRH—hypothyroidism	0.000197	0.00102	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TRH—hypothyroidism	0.000195	0.00101	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AVP—hypothyroidism	0.000193	0.000997	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	0.000191	0.000988	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3C2A—hypothyroidism	0.000187	0.000968	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—SLC5A5—hypothyroidism	0.000182	0.000944	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—VAV3—hypothyroidism	0.000182	0.00094	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	0.00018	0.000931	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TSHB—hypothyroidism	0.000175	0.000908	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TSHR—hypothyroidism	0.000175	0.000908	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AVP—hypothyroidism	0.000175	0.000906	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TSHR—hypothyroidism	0.000174	0.000899	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TSHB—hypothyroidism	0.000174	0.000899	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AVP—hypothyroidism	0.000173	0.000897	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—SLC5A5—hypothyroidism	0.00017	0.00088	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—SLC5A5—hypothyroidism	0.000157	0.000813	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SH2B3—hypothyroidism	0.000156	0.000809	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	0.000155	0.000801	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—POMC—hypothyroidism	0.000128	0.000663	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	0.000127	0.000656	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—POMC—hypothyroidism	0.000116	0.000602	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PRL—hypothyroidism	0.000116	0.0006	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—POMC—hypothyroidism	0.000115	0.000596	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PRL—hypothyroidism	0.000115	0.000594	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—VAV3—hypothyroidism	0.000107	0.000555	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—POMC—hypothyroidism	0.000107	0.000553	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—VAV3—hypothyroidism	0.000106	0.00055	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AVP—hypothyroidism	0.000103	0.000535	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AVP—hypothyroidism	0.000102	0.00053	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—POMC—hypothyroidism	9.54e-05	0.000494	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—POMC—hypothyroidism	8.89e-05	0.00046	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—POMC—hypothyroidism	8.21e-05	0.000425	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—POMC—hypothyroidism	6.87e-05	0.000356	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—POMC—hypothyroidism	6.8e-05	0.000352	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IGF1—hypothyroidism	6.61e-05	0.000342	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IGF1—hypothyroidism	6.54e-05	0.000339	CbGpPWpGaD
